Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis

Description

Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages the walls of veins, which results in stenosis at the local site. This condition is called central venous stenosis (CVS) and affects number of patients on hemodialysis in the United States and can compromise the dialysis efficacy. The current diagnostic modality for CVS is venography, which has several limitations. This study proposes to examine intravenous ultrasound (IVUS) as a potentially superior modality, which will provide additional information.

Conditions

End Stage Renal Disease

Study Overview

Study Details

Study overview

Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages the walls of veins, which results in stenosis at the local site. This condition is called central venous stenosis (CVS) and affects number of patients on hemodialysis in the United States and can compromise the dialysis efficacy. The current diagnostic modality for CVS is venography, which has several limitations. This study proposes to examine intravenous ultrasound (IVUS) as a potentially superior modality, which will provide additional information.

Role of Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis

Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis

Condition
End Stage Renal Disease
Intervention / Treatment

-

Contacts and Locations

Boston

Boston Medical Center, Boston, Massachusetts, United States, 02118

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * ESRD (end stage renal disease) patients at BMC (Boston Medical Center)
  • * Receiving hemodialysis
  • * Has a dialysis access malfunction
  • * Undergoing a diagnostic fistulogram for the dialysis access malfunction
  • * None

Ages Eligible for Study

18 Years to 85 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Boston Medical Center,

Vipul Chitalia, MD PhD, PRINCIPAL_INVESTIGATOR, Boston Medical Center

Study Record Dates

2024-12